Krka's Q1 net profit declines 2% to EUR 89m

Novo Mesto, 18 May - Pharma company Krka reported a group net profit of EUR 89 million for the first quarter, down 2% year-on-year. Revenue rose by 6% to EUR 458 million despite a slight drop in the company's key Eastern European sales region, according to an interim report released on Thursday.